Pfizer, Endo Pay $50M To Settle Drug Price Inflation Claims
Texas authorities said Friday that Pfizer Inc. and Endo Pharmaceuticals Inc. each coughed up $25 million to settle allegations their subsidiaries reported inflated drug prices to Texas' Medicaid program, the latest...To view the full article, register now.
Already a subscriber? Click here to view full article